Clarivate Epidemiology’s coverage of chronic heart failure (CHF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed prevalence of…
Clarivate Epidemiology’s coverage of chronic heart failure (CHF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed prevalence of…
Clarivate Epidemiology’s coverage of chronic heart failure (CHF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed prevalence of…
The primary goal of hemophilia A treatment is to prevent bleeding. Hemophilia A patients are a heterogeneous cohort; the tendency to bleed is highly individual. Currently available treatments…
MARKET OVERVIEWChronic hand eczema (CHE) is a painful and debilitating form of eczema localized to the hands that can seriously impact a patient’s quality of life. No prescription therapies are…
Clarivate’s Epidemiology’s coverage of the shingles vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France…
Clarivate Epidemiology’s coverage of the Hepatitis B vaccine (HBV) vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United…
Clarivate’s Epidemiology’s coverage of pneumococcal vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States,…